Key result
Two intrinsically disordered, hydrophobic peptide tails in human clusterin enable its diverse activities, including suppressing protein aggregation, binding to receptors, and lipoprotein formation.
Why the study?
Despite the prominent role of clusterin in extracellular proteostasis, its chaperone mechanism has remained unclear.
The identification of disordered hydrophobic tails in clusterin explains its versatile ability to function as an extracellular chaperone and facilitate the clearance of misfolded proteins.
Identifies targets for modulating clusterin function; leaves open clinical applications in aggregation-related disorders.
Clusterin, a conserved secretory glycoprotein abundant in blood plasma and cerebrospinal fluid, functions as a molecular chaperone and apolipoprotein (Wyatt et al. 2013, Raulin et al. 2022). Dysregulation of clusterin is linked to late-onset Alzheimer’s disease, cardiovascular pathology and cancer (Rohne et al. 2016, Satapathy and Wilson 2021, Wilson et al. 2023). Despite its prominent role in extracellular proteostasis, the chaperone mechanism of clusterin has remained unclear. Here we present crystal structures of human clusterin, revealing a discontinuous three-domain architecture. Structure-based mutational analysis demonstrated that two intrinsically disordered, hydrophobic peptide tails enable diverse clusterin activities. Resembling the N-terminal substrate binding regions of so-called small heat shock proteins, these sequences mediate clusterin’s chaperone function in suppressing amyloid-β, tau and α-synuclein aggregation. In conjunction with highly conserved surface areas, the tail segments also participate in clusterin binding to very low density lipoprotein receptor (VLDLR) and cellular uptake. Moreover, the disordered tails cooperate with an adjacent amphipathic helix in lipoprotein formation, but remain accessible for chaperone function in the lipoprotein complex. The remarkable versatility of these sequences allows clusterin to function alone or bound to lipid in maintaining solubility of aberrant extracellular proteins and facilitating their clearance by endocytosis and lysosomal degradation.
No takes yet. Share an insight, caveat, or question.
Yuste‐Checa et al. (2024) studied this question. Clusterin mutations (hydrophobic tails) vs. Wild-type clusterin was evaluated on Chaperone activity, receptor binding, and lipoprotein formation. Two intrinsically disordered, hydrophobic peptide tails in human clusterin enable its diverse activities, including suppressing protein aggregation, binding to receptors, and lipoprotein formation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: